Insider Stock Trading History of Nashat Amir


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nashat Amir since year 2005. The trader's CIK number is 1575843. At the time of this reporting, Nashat Amir is the Director of Selecta Biosciences Inc . (stock ticker symbol SELB). See this page for all insider trading activities at Selecta Biosciences Inc .

Note that in the past Nashat Amir also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Nashat Amir since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-26 SELB Selecta Biosciences Inc Sale 70,226 18.91 1,328,114
2017-09-22 SELB Selecta Biosciences Inc Sale 42,036 19.26 809,781
2017-09-25 SELB Selecta Biosciences Inc Sale 37,175 18.99 705,878
2017-09-20 SELB Selecta Biosciences Inc Sale 42,610 20.03 853,393
2017-09-21 SELB Selecta Biosciences Inc Sale 104,577 19.86 2,076,794
2016-07-06 SYRS Syros Pharmaceuticals, Inc. Buy 400,000 12.50 5,000,000
2016-06-27 SELB Selecta Biosciences Inc Buy 150,000 14.00 2,100,000
2013-12-06 RCPT Receptos, Inc. Sale 170,000 27.29 4,639,300
2013-11-20 RCPT Receptos, Inc. Sale 30,685 22.77 698,697
2013-11-14 RCPT Receptos, Inc. Sale 154,089 25.00 3,852,225
2013-11-15 RCPT Receptos, Inc. Sale 15,226 24.54 373,646
2013-10-04 FATE Fate Therapeutics Inc Buy 833,333 6.00 4,999,998
2013-05-14 RCPT Receptos, Inc. Buy 151,343 14.00 2,118,802

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nashat Amir (Director of Selecta Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.